Abstract
Microglia are the immune cells of the brain involved in regulation and maintenance of brain micro-environment. These cells not only play imperative role in shaping the brain neural networks during development but also protect the brain from any disparaging condition throughout the life as first line of combatants. Interestingly, these cells exhibit dual nature in various neuropathological conditions. Depending upon the quantum of brain insult, they acquire different morphology which in favour either suppress the severity or aggravate the situation by releasing several immune-mediated molecules. This review summarizes the properties of microglia in healthy and diseased brain and explains their dual nature in various neuropathological disorders.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40011-015-0585-y/MediaObjects/40011_2015_585_Fig1_HTML.gif)
Similar content being viewed by others
References
Del Rio-Hortega P (1932) Microglia. In: Penfield W (ed) Cytology and cellular pathology of the nervous system. Paul B Hoeber, New York, pp 482–534
Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213:48–65
Pont-Lezica L, Béchade C, Belarif-Cantaut Y, Pascual O, Bessis A (2011) Physiological roles of microglia during development. J Neurochem 119(5):901–908
Nayak D, Roth TL, McGavern DB (2014) Microglia development and function. Annu Rev Immunol 32:367–402
Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B (2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74(4):691–705
Ginhoux F, Lim S, Hoeffel G, Low D, Huber T (2013) Origin and differentiation of microglia. Front Cell Neurosci 7:45
Neiva I, Malva JO, Valero J (2014) Can we talk about microglia without neurons? A discussion of microglial cell autonomous properties in culture. Front Cell Neurosci 8:202
Prinz M, Mildner A (2011) Microglia in the CNS: immigrants from another world. Glia 59(2):177–187
Gomez Perdiguero E, Schulz C, Geissmann F (2013) Development and homeostasis of “resident” myeloid cells: the case of the microglia. Glia 61(1):112–120
Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R (2014) Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med 211(8):1533–1549
Prinz M, Priller J (2014) Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15(5):300–312
Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308(5726):1314–1318
Hellwig S, Heinrich A, Biber K (2013) The brain’s best friend: microglial neurotoxicity revisited. Front Cell Neurosci 7:71
Niquet J, Ben-Ari Y, Repressa A (1994) Glial reaction after seizure induced hippocampal lesion: immunohistochemical characterization of proliferating glial cells. J Neurocytol 23(10):641–656
Benoit M, Desnues B, Mege JL (2008) Macrophage polarization in bacterial infections. J Immunol 181(6):3733–3739
Luo XG, Chen SD (2012) The changing phenotype of microglia from homeostasis to disease. Transl Neurodegener 1:9
Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453–461
Gregory CD, Devitt A (2004) The macrophage and the apoptotic cell: an innate immune interaction viewed simplistically? Immunology 113:1–14
Colton CA (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 4:399–418
Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev 11(11):775–787
Boya J, Calvo JL, Carbonell AL, Borregon A (1991) A lectin histochemistry study on the development of rat microglial cells. J Anat 175:229–236
Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S et al (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330(6005):841–845
Monier A, Evrard P, Gressens P et al (2006) Distribution and differentiation of microglia in the human encephalon during the first two trimesters of gestation. J Comp Neurol 499(4):565–582
Rezaie P, Male D (2002) Mesoglia and microglia—a historical review of the concept of mononuclear phagocytes within the central nervous system. J Hist Neurosci 11(4):325–374
Alliot F, Lecain E, Grima B, Pessac B (1991) Microglial progenitors with a high proliferative potential in the embryonic and adult mouse brain. Proc Natl Acad Sci USA 88(4):1541–1545
Hickey WF, Vass K, Lassmann H (1992) Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 51(3):246–256
Lassmann H, Hickey WF (1993) Radiation bone marrow chimeras as a tool to study microglia turnover in normal brain and inflammation. Clin Neuropathol 12(5):284–285
Shepard JL, Zon LI (2000) Developmental derivation of embryonic and adult macrophages. Curr Opin Hematol 7(1):3–8
Takahashi K (2001) Development and differentiation of macrophages and related cells: historical review and current concepts. J Clin Exp Hematop 41:1–33
Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290–292
Yokoyama A, Yang L, Itoh S, Mori K, Tanaka J (2004) Microglia, a potential source of neurons, astrocytes and oligodendrocytes. Glia 45(1):96–104
Matsuda S, Niidome T, Nonaka H, Goto Y, Fujimura K, Kato M et al (2008) Microtubule-associated protein 2-positive cells derived from microglia possess properties of functional neurons. Biochem Biophys Res Commun 368(4):971–976
Rakic S, Zecevic N (2000) Programmed cell death in the developing human telencephalon. Eur J Neurosci 12(8):2721–2734
Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P et al (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333(6048):1456–1458
Schafer DP, Lehrman EK, Stevens B (2013) The ‘‘Quad-Partite’’ synapse: microglia-synapse interactions in the developing and mature CNS. Glia 61(1):24–36
Farinas I, Cano-Jaimez M, Bellmunt E, Soriano M (2002) Regulation of neurogenesis by neurotrophins in developing spinal sensory ganglia. Brain Res Bull 57(6):809–816
Miller FD, Kaplan DR (2001) Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 58(8):1045–1053
Nakajima K, Honda S, Tohyama Y, Imai Y, Kohsaka S, Kurihara T (2001) Neurotrophin secretion from cultured microglia. J Neurosci Res 65(4):322–331
Bansal R (2002) Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. Dev Neurosci 24(1):35–46
Thored P, Heldmann U, Gomes-Leal W, Gisler R, Darsalia V, Taneera J et al (2009) Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia 57(8):835–849
Tremblay MÈ, Lowery RL, Majewska AK (2010) Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8:e1000527
Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29(13):3974–3980
Aloisi F (2001) Immune function of microglia. Glia 36(2):165–179
Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158(3):1021–1029
Gomes-Leal W (2012) Microglial physiopathology: how to explain the dual role of microglia after acute neural disorders? Brain Behav 2(3):345–356
Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, Hempstead BL, Littman DR, Gan WB (2013) Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155(7):1596–1609
Elmore MR, Najafi AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL, Green KN (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82(2):380–397
Hughes EG, Bergles DE (2014) Hidden progenitors replace microglia in the adult brain. Neuron 82(2):253–255
Ben Achour S, Pascual O (2010) Glia: the many ways to modulate synaptic plasticity. Neurochem Int 57(4):440–445
Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91(2):461–553
Hayashi Y, Ishibashi H, Hashimoto K, Nakanishi H (2006) Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia 53(6):660–668
Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA et al (2011) CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci 31(45):16241–16250
Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K et al (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438(7070):1017–1021
Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A (2012) Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci USA 109(4):E197–E205
Tremblay MÈ, Zettel ML, Ison JR, Allen PD, Majewska AK (2012) Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia 60(4):541–558
Yung RL, Julius A (2008) Epigenetics, aging and autoimmunity. Autoimmunity 41(4):329–335
Streit WJ, Sammons NW, Kuhns AJ, Sparks DL (2004) Dystrophic microglia in the aging human brain. Glia 45(2):208–212
Kushwaha S (2009) Age related changes in astrocytes and microglia in hippocampus and striate cortex. PhD Thesis, Jiwaji University, Gwalior, India, p 93
Streit WJ (2006) Microglial senescence: does the brain’s immune system have an expiration date? Trends Neurosci 29(9):506–510
Godbout JP, Johnson RW (2009) Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Immunol Allergy Clin North Am 29(2):3213–3237
Sierra A, Gottfried-Blackmore AC, McEwen BS, Bulloch K (2007) Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55(4):412–424
Wynne AM, Henry CJ, Godbout JP (2009) Immune and behavioral consequences of microglial reactivity in the aged brain. Integr Comp Biol 49(3):254–266
Dilger RN, Johnson RW (2008) Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol 84(4):932–939
Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW (2008) Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun 22(3):301–311
Mutnal MB, Hu S, Little MR, Lokensgard JR (2011) Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ. J Neurovirol 17(5):424–437
Patro IK, Pathak S, Patro N (2005) Central responses to peripheral nerve injury: role of non-neuronal cells. In: Thakur MK, Prasad S (eds) Molecular and cellular neurobiology. Narosa publishing house, Delhi, p 217
Patro IK, Nagayach A, Patro N (2010) Iba1 expressing microglia in the dorsal root ganglia become activated following peripheral nerve injury in rats. Indian J Exp Biol 48(2):110–116
Patro N, Patro IK (2004) Effect of immunactivator (poly I:C) on the rat cerebral cortex. J Tissue Res 4(1):71–74
Patro IK, Amit Shrivastava M, Bhumika S, Patro N (2010) Poly I: C induced microglial activation impairs motor activity in adult rats. Indian J Exp Biol 48:104–109
Davies CA, Loddick SA, Stroemer RP, Hunt J, Rothwell NJ (1998) An integrated analysis of the progression of cell responses induced by permanent focal middle cerebral artery occlusion in the rat. Exp Neurol 154(1):199–212
Nagayach A, Patro N, Patro I (2014) Experimentally induced diabetes causes glial activation, glutamate toxicity and cellular damage leading to changes in motor function. Front Cell Neurosci 8:355. doi:10.3389/fncel.2014.00355
Nagayach A, Patro N, Patro I (2014) Astrocytic and microglial response in experimentally induced diabetic rat brain. Metab Brain Dis 29(3):747–761
Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40(2):140–155
Suzumura A (2002) Microglia: immunoregulatory cells in the central nervous system. Nagoya J Med Sci 65(1–2):9–20
Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387–1394
Rivest S (2003) Molecular insights on the cerebral innate immune system. Brain Behav Immun 17(1):13–19
Sondag CM, Dhawan G, Combs CK (2009) Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 6:1
Chao CC, Hu S, Gekker G, Novick WJ Jr, Remington JS, Peterson PK (1993) Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J Immunol 150(8 Pt 1):3404–3410
Möller T, Weinstein JR, Hanisch UK (2006) Activation of microglial cells by thrombin: past, present and future. Semin Thromb Hemost 32(Suppl 1):69–76
Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81(2):741–766
Itagaki S, Mcgeer PL, Akiyama H, Zhu S, Selkoe D (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24(3):173–182
Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12(9):1005–1015
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21(3):383–421
Sheng JG, Mrak RE, Griffin WS (1997) Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alphamicroglia and S100beta-astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 56:285–290
Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 88:7552–7556
Li Y, Liu L, Barger SW, Griffin WS (2003) Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 23(5):1605–1611
Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53(3):337–351
Streit W, Braak H, Xue QS, Bechmann I (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol 118:475–485
Krause DL, Müller N (2010) Neuroinflammation, microglia and implications for anti–Inflammatory treatment in Alzheimer’s disease. Int J Alzheimers Dis. doi:10.4061/2010/732806
Mizuno T (2012) The biphasic role of microglia in Alzheimer’s disease. Int J Alzheimer’s Dis, Article ID 737846, 9 p
Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML et al (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease. FASEB J 19(6):533–542
Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains. Acta Neuropathol 106(6):518–526
Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003) The role of glial reaction and inflammation in Parkinson’s disease. Ann NY Acad Sci 991:214–218
Standaert DG, Theodore S, Cao SW, McLean P (2009) α-Synuclein triggers microglial activation and adaptive immunity in a mouse model of Parkinson disease. Neurology 72:A438
Tambuyzer BR, Ponsaerts P, Nouwen EJ (2009) Microglia: gatekeepers of central nervous system immunology. J Leukoc Biol 85(3):352–370
Peterson LJ, Flood PM (2012) Oxidative stress and microglial cells in Parkinson’s disease. Mediat Inflamm 2012:401264. doi:10.1155/2012/401264
Polazzi E, Altamira LEP, Eleuteri S, Barbaro R, Casadio C, Contestabile A, Monti B (2009) Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor β-2. J Neurochem 110(2):545–556
Ramsey CP, Tansey MG (2014) A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson’s disease and potential molecular targets. Exp Neurol 256:126–132
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502–1517
Giunti D, Parodi B, Cordano C, Uccelli A, Kerlero de Rosbo N (2014) Can we switch microglia’s phenotype to foster neuroprotection? Focus multiple sclerosis. Immunology 141(3):328–339
Jiang Z, Jiang JX, Zhang GX (2014) Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett 160(1):17–22
Prinz M, Tay TL, Wolf Y, Jung S (2014) Microglia: unique and common features with other tissue macrophages. Acta Neuropathol. doi:10.1007/s00401-014-1267-1
Chastain EM, Duncan DS, Rodgers JM, Miller SD (2011) The role of antigen presenting cells in multiple sclerosis. Biochim Biophys Acta 1812:265–274
Bhasin M, Wu M, Tsirka SE (2007) Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol 8:10
Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, Schwartz A, Smirnov I, Pollack A, Jung S, Schwartz M (2006) Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Investig 116(4):905–915
Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJ, ffrench-Constant C (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16(9):1211–1218
Merson TD, Binder MD, Kilpatrick TJ (2010) Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. NeuroMol Med 12(2):99–132
Napoli I, Neumann H (2009) Microglial clearance function in health and disease. Neuroscience 158(3):1030–1038
van Horssen J, Singh S, van der Pol S, Kipp M, Lim JL, Peferoen L, Gerritsen W, Kooi EJ, Witte ME, Geurts JJ, de Vries HE, Peferoen-Baert R, van den Elsen PJ, van der Valk P, Amor S (2012) Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation. J Neuroinflamm 9:156
Appel SH, Zhao W, Beers DR, Henkel JS (2011) The Microglial-motoneuron dialogue in ALS. Acta Myol 30(1):4–8
Boillée S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G et al (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312(5778):1389–1392
Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ et al (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an (11C) (R)-PK11195 positron emission tomography study. Neurobiol Dis 15(3):601–609
Hall ED, Oostveen JA, Gurney ME (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249–256
Dewil M, Van Den Bosch L, Robberecht W (2007) Microglia in amyotrophic lateral sclerosis. Acta Neurol Belg 107(3):63–70
Chiu IM, Chen A, Zheng Y et al (2008) T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci USA 105:17913–17918
Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R (2003) Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice. Exp Neurol 183(1):25–33
Weinstein JR, Koerner IP, Möller T (2011) Microglia in ischemic brain injury. Future Neurol 5(2):227–246
Lai AY, Todd KG (2006) Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines. Glia 53(8):809–816
Pun PB, Lu J, Moochhala S (2009) Involvement of ROS in BBB dysfunction. Free Radic Res 43(4):348–364
Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K (2006) Microglia provide neuroprotection after ischemia. FASEB J 20(6):714–716
Denes A, Vidyasagar R, Feng J et al (2007) Proliferating resident microglia after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 27(12):1941–1953
Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19(5):1708–1716
Hsiao Y, Chern Y (2009) Targeting glial cells to elucidate the pathogenesis of Huntington’s disease. Mol Neurobiol 41(2–3):248–255
Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA et al (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66(11):1638–1643
Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, Cattaneo E et al (2014) Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci 17(4):513–521
Giorgini F, Moller T, Kwan W, Zwilling D, Wacker JL, Hong S et al (2008) Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment. J Biol Chem 283(12):7390–7400
Kwan W, Träger U, Davalos D, Chou A, Bouchard J, Andre R et al (2012) Mutant huntingtin impairs immune cell migration in Huntington disease. J Clin Invest 122(12):4737–4747
Björkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington’s disease. J Exp Med 205(8):1869–1877
Milnerwood AJ, Raymond LA (2010) Early synaptic pathophysiology in neurodegeneration: insights from Huntington’s disease. Trends Neurosci 33(11):513–523
Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E et al (2009) Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitoxicity. Brain 132(Pt 11):3152–3164
Van Everbroeck B, Dewulf E, Pals P, Lübke U, Martin JJ, Cras P (2002) The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging 23(1):59–64
Brown DR, Besinger A, Herms JW, Kretzschmar HA (1998) Microglial expression of the prion protein. Neuroreport 9(7):1425–1429
Brown DR (2001) Microglia and prion disease. Microsc Res Tech 54(2):71–80
Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol 8(3):449–557
Guiroy DC, Wakayama I, Liberski PP, Gajdusek DC (1994) Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler syndrome. Acta Neuropathol 87(5):526–530
Peyrin M, Lasmézas CI, Haïk S, Tagliavini F, Salmona M, Williams A et al (1999) Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. Neuroreport 10(4):723–729
Shi F, Yang L, Kouadir M, Yang Y, Wang J, Zhou X, Yin X, Zhao D (2012) The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation. J Neuroinflammation 9:73. doi:10.1186/1742-2094-9-73
Lorger M (2012) Tumor microenvironment in the brain. Cancers 4(1):218–243
Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489–501
Guo P, Imanishi Y, Cackowski FC, Jarzynka MJ, Tao HQ, Nishikawa R et al (2005) Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol 166(3):877–890
Leung SY, Wong MP, Chung LP, Chan AS, Yuen ST (1997) Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol 93(5):518–527
Watters JJ, Schartner JM, Badie B (2005) Microglia function in brain tumors. J Neurosci Res 81(3):447–455
Glass R, Synowitz M, Kronenberg G, Walzlein JH, Markovic DS, Wang LP et al (2005) Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci 25(10):2637–2646
Schartner JM, Hagar AR, Van Handel M, Zhang L, Nadkarni N, Badie B (2005) Impaired capacity for upregulation of MHC class II in tumour-associated microglia. Glia 51(4):279–285
Graeber MB, Scheithauer BW, Kreutzberg GW (2002) Microglia in brain tumours. Glia 40(2):252–259
Sliwa M, Markovic D, Gabrusiewicz K, Synowitz M, Glass R, Zawadzka M et al (2007) The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain 130(Pt 2):476–489
Murata J, Ricciardi-Castagnoli P, Dessousl’eglise Mange P, Martin F, Juillerat-Jeanneret L (1997) Microglial cells induce cytotoxic effects toward colon carcinoma cells: measurement of tumor cytotoxicity with a gamma-glutamyl transpeptidase assay. Int J Cancer 70(2):169–174
Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239(4840):586–592
Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Xj Liu, Stins M et al (1999) Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155(5):1599–1611
D’Aversa TG, Eugenin EA, Berman JW (2005) NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res 81(3):436–446
Williams KC, Hickey WF (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neuorsci 25:537–562
Persidsky Y, Gendelman HE (2003) Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 74(5):691–701
Tripathi S, Patro I, Mahadevan A, Patro N, Phillip M, Shankar SK (2014) Glial alterations in tuberculous and cryptococcal meningitis and their relation to HIV co-infection—a study on human brains. J Infect Dev Ctries 8(11):1421–1443
Marker DF, Puccini JM, Mockus TE, Barbieri J, Lu SM, Gelbard HA (2012) LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein. J Neuroinflammation 9:261
Gelbard HA, Dewhurst S, Maggirwar SB, Kiebala M, Polesskaya O, Gendelman HE (2010) Rebuilding synaptic architecture in HIV-1 associated neurocognitive disease: a therapeutic strategy based on modulation of mixed lineage kinase. Neurotherapeutics 7(4):392–398
Parthasarathy G, Philipp MT (2012) Review: apoptotic mechanisms in bacterial infections of the central nervous system. Front Immunol 3:306
Ovanesov MV, Moldovan K, Smith K, Vogel MW, Pletnikov MV (2008) Persistent borna disease virus (BDV) infection activates microglia prior to a detectable loss of granule cells in the hippocampus. J Neuroinflammation 5:16
Thongtan T, Thepparit C, Smith DR (2012) The involvement of microglial cells in Japanese encephalitis infections. Clin Dev Immunol 2012:890586
Nau R, Bruck W (2002) Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 25(1):38–45
Deininger MH, Kremsner PG, Meyermann R, Schluesener H (2002) Macrophages/microglial cells in patients with cerebral malaria. Eur Cytokine Netw 13(2):173–185
Kielian T (2006) Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83(5):711–730
Block ML, Zecca L, Hong JS (2007) Microglia–mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57–69
Daulhac L, Maffre V, Mallet C, Etienne M, Privat AM, Kowalski-Chauvel A et al (2011) Phosphorylation of spinal N-methyl D-aspartate receptor NR1 subunits by extracellular signal-regulated kinase in the spinal dorsal horn neurons and microglia contributes to diabetes-induced painful neuropathy. Eur J Pain 15:169.e1–169.e12
Grigsby JG, Cardona SM, Pouw CE, Muniz A, Mendiola AS, Tsin AT et al (2014) The role of microglia in diabetic retinopathy. J Ophthalmol 2014:705783
Wang D, Couture R, Hong Y (2014) Activated microglia in the spinal cord underlies diabetic neuropathic pain. Eur J Pharmacol 728:59–66
Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10(1):23–36
Ji RR, Berta T, Nedergaard M (2013) Glia and pain: is chronic pain a gliopathy? Pain 154(Suppl 1):S10–S28
Svensson CI, Marsala M, Westerlund A, Calcutt NA, Campana WM, Freshwater JD et al (2003) Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 86:1534–1544
Ji RR, Suter MR (2007) P38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3:33
Tanga FY, Nutile-McMenemy N, De Leo JA (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 102:5856–5861
Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY et al (2007) A critical role of Toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 282:14975–14983
Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K et al (2008) Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem 105:2249–2259
Scholz J, Woolf CJ (2007) The neuropathic pain triad: neurons, immune cells, and glia. Nature Neurosci 10:1361–1368
Tsuda M, Inoue K, Salter MW (2005) Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia. Trends Neurosci 28:101–107
Ashton JC, Glass M (2007) The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol 5:73–80
Watkins LR, Maier SF (2003) Glia: a novel drug discovery target for clinical pain. Nature Rev Drug Discov 2:973–985
Romero-Sandoval EA, Horvath RJ, Deleo JA (2008) Neuroimmune interactions and pain: focus on glial modulating targets. Curr Opin Investig Drugs 9:726–734
Acknowledgments
Financial support from the Department of Biotechnology and Indian Council of Medical Research, New Delhi is thankfully acknowledged. Aarti Nagayach is an Indian Council of Medical Research (ICMR) Senior Research Fellow. Facilities developed through the DBT-Human Resource Development and Bioinformatics Infrastructural facility through Department of Biotechnology Grants used in this study are thankfully acknowledged.
Conflict of interest
Authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nagayach, A., Patro, N. & Patro, I. Microglia in the Physiology and Pathology of Brain. Proc. Natl. Acad. Sci., India, Sect. B Biol. Sci. 86, 781–794 (2016). https://doi.org/10.1007/s40011-015-0585-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40011-015-0585-y